Meningococcal B Vaccine and Meningococcal Carriage in Adolescents in Australia
2020; Massachusetts Medical Society; Volume: 382; Issue: 4 Linguagem: Inglês
10.1056/nejmoa1900236
ISSN1533-4406
AutoresHelen Marshall, Mark McMillan, Ann P. Koehler, Andrew J. Lawrence, Thomas Sullivan, Jenny MacLennan, Martin Maiden, Shamez Ladhani, Mary Ramsay, Caroline Trotter, Ray Borrow, Adam Finn, Charlene M. Kahler, Jane Whelan, Kumaran Vadivelu, Peter Richmond,
Tópico(s)Virology and Viral Diseases
ResumoThe meningococcal group B vaccine 4CMenB is a new, recombinant protein-based vaccine that is licensed to protect against invasive group B meningococcal disease. However, its role in preventing transmission and, therefore, inducing population (herd) protection is uncertain.
Referência(s)